Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bernad A et al. Immunity 1994; 1: 725–731.
Yoshida K et al. Proc Natl Acad Sci USA 1996; 93: 407–411.
Zandstra PW et al. Proc Natl Acad Sci USA 1997; 94: 4698–4703.
Bryder D, Jacobsen SEW . Blood 2000; 96: 1748–1755.
Rane SG, Reddy EP . Oncogene 2002; 21: 3334–3358.
Takeda K et al. Proc Natl Acad Sci USA 1997; 94: 3801–3804.
Bunting KD et al. Blood 2002; 99: 479–487.
Encabo A et al. Haematologica 2003; 88: 386–393.
Audet J et al. Proc Natl Acad Sci USA 2001; 98: 1757–1762.
Luens KM et al. Blood 1998; 91: 1206–1215.
de Wynter EA et al. Stem Cells 1998; 16: 387–396.
Darnell Jr. JE . Science 1997; 277: 1630–1635.
Hsu J-h et al. Oncogene 2004; 23: 3368–3375.
von Gise A et al. Mol Cell Biol 2001; 21: 2324–2336.
Singh S, Aggarwal BB . J Biol Chem 1995; 270: 24995–25000.
Kato Y et al. J Exp Med 2005; 202: 169–179.
Bradley HL et al. Blood 2002; 100: 3983–3989.
Schuringa JJ et al. J Exp Med 2004; 200: 623–635.
Oh I-H, Eaves CJ . Oncogene 2002; 21: 4778–4787.
Acknowledgements
We thank members of the laboratory of Cord Blood Bank of Valencian Community for providing umbilical cord blood specimens. This work was supported by Grants FIS 01/0066-03 and CP03/00136.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sepúlveda, P., Encabo, A., Carbonell-Uberos, F. et al. BCL-2 expression is mainly regulated by JAK/STAT3 pathway in human CD34+ hematopoietic cells. Cell Death Differ 14, 378–380 (2007). https://doi.org/10.1038/sj.cdd.4402007
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.cdd.4402007
This article is cited by
-
A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer
Cell Death & Disease (2022)
-
8-Hydroxyquinoline a natural chelating agent from Streptomyces spp. inhibits A549 lung cancer cell lines via BCL2/STAT3 regulating pathways
World Journal of Microbiology and Biotechnology (2022)
-
Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2V617F cells
Investigational New Drugs (2020)
-
Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
Scientific Reports (2019)
-
IL-13 in LPS-Induced Inflammation Causes Bcl-2 Expression to Sustain Hyperplastic Mucous cells
Scientific Reports (2018)
